Disclosure Issues in the Life Sciences Industry

Wednesday, October 30, 2024
12:00 PM - 01:00 PM Eastern Daylight Time
11:00 AM - 12:00 PM Central Daylight Time
09:00 AM - 10:00 AM Pacific Daylight Time

Join us in discussing disclosure considerations for public companies in the life sciences sector. Our speakers will delve into the industry’s intricacies and challenges, with a particular emphasis on the nuances relevant to biotech companies.

Topics will include:

  • Background on disclosure obligations 
  • Materiality standard and caselaw 
  • Intersection of disclosure obligations and the US Food and Drug Administration
    • Crafting disclosures to comply with FDA standards (overview of FDA promotional and scientific exchange standards, as applied to investor communications)
    • Regulatory strategy and disclosure strategy
    • Common regulatory developments that may have disclosure implications
  • Partnerships, licensing arrangements, collaborations, and disclosures  

CLE credit: CLE credit in CA, IL, IN, LA, NY, OH, PA, TX, and VA is currently pending approval. Credit in CT, FL, and NJ is pending approval via reciprocity.